Thomas Gilley

Thomas Gilley (board member) discloses dealings in BIO KEY International Inc to SEC (Form 4). Over a trading history stretching from 13 August 2015 to 10 November 2022, the count stands at 37 filings.

Purchases make up the whole of the open-market record (3 purchases, €7,932). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 34 share grants.

Half of the purchases are above €1,271 and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days. Ninety days after publication, 3 purchases show a median change of +8.3%, with the price up in 100% of them. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 14 November 2022 with a share grant in BIO KEY International Inc. The clock since the last published purchase (7 June 2016) now reads 3,807 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.